We would love to hear your thoughts about our site and services, please take our survey here.
I suspect he is still licking his wounds as to why the Bioasis deal fell through - this has been manipulated IMO, somewhat out of his control. Now we have huge dilution with countless warrants hanging over us. Only major news would lift us out of the doldrums. I'm averaging 10p, which once upon a time was not too shabby. Now I need to decide whether to average down more... painful
LTH sadly - screwed at every turn
some chunky sells pm - mirroring new all time lows in US.
Feel like we will be stuck down the 1p -1.50p range for a while until a miracle happens
Something must have shored up the investment… the pipeline needs to start bearing fruit for Midatech. Hopefully that becomes the focus in the short to mid term this year whilst there is a decent cash runway.
We’re actually trading on par with US at 0.65p so much of this is factored in to our 2p-2.5p current range
Hopefully sentiment will change now we can put the risk of administration behind us.
Either that or insolvency.
Why ever the US holders didn’t vote for the Bioasis deal I don’t know.
0.58c - roughly 1.9p
The net proceeds received from the Private Placement will enable the Company to focus on developing its clinical asset, MTX110, and, alongside cost-cutting initiatives, are expected to provide the Company with sufficient working capital to December 2023. The Company expects to report completion of treatment in the second investigator initiated Phase I study in rare orphan Diffuse Intrinsic Pontine Glioma (DIPG) in Q2 2023. The Company also expects to report initial progression free survival (PFS) clinical data from its Phase I study in recurrent Glioblastoma (GBM) in Q3 2023.
$6m private placing
Seems to be some support both here and across the pond - I can’t imagine Stamp isn’t working on a plan here. If he can pull a rabbit out of the hat with funding this will fly as it is massively undervalued with a £2m MCAP. The MAGIC-G1 phase I clinical study is going well and has increased the number of test patients recently. Within their original pipeline there are many opportunities to attract investment… hopefully not at the behest of LTH’s once more. GLA
It was news of the ‘merger’ that dropped us from 6p to 2.5p - ironically the news that it had been voted against dropped us briefly to 1.5p - securing funding now would see a return to 6p+ in the short term but ultimately we need firm news on the progress of their pipeline. GLA
I meant that everyone voting 'no' on the merger knew the alternative outcome - cash until March or else. Why would you vote against it unless you knew something better than the merger option was in the pipeline?
Shareholders said no… why would they choose certain liquidation over an opportunity to build… unless directed in some way to do so by information unbeknown to the private investor
Held up in the US - actually finished green out of hours. Clearly the deal with Bioasis not popular there… though I would have preferred that over liquidation. Hopefully we have an 11th hour deal here but surely this would have been forthcoming before approaching Bioasis in the first place. What a mess Stamp. I’m currently over £30k in the hole here
That’s two words..
took a battering in the US yesterday - its a shorters market until volume arrives. Hopefully we hold or lead the way today. Only MTP releases good news and sees a drop! Jitters about whether the deal will be approved perhaps?
GLA
Agree… or else!
Hopefully we’ve seen the bottom here.
Happy New Year all!
Should be interesting to understand the wider sentiment from this call
Still over 50% down from last Monday… which was itself around 80% down from previous years so can’t get too excited. Wish I’d have averaged down at 2.1p
This RNS suggests otherwise!